Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both slowed the progression of the memory-robbing illness.

Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both ...

A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.

WHEN you’re staring down the barrel of 50, it feels as though your brain is slowly deflating. But there’s a new ‘magic’ ...